Bridgebio Pharma, Inc. · NASDAQ:BBIO

Viking Global Investors LP reported a 6.10% stake in Bridgebio Pharma, Inc. (Schedule 13D/A)

Event Mar 31, 2026 · Filed Apr 2, 2026

Viking Global Investors LP reported a 6.10% stake in Bridgebio Pharma, Inc., 11,842,434 shares, with active intent on Mar 31, 2026. Filed Apr 2, 2026 (Schedule 13D/A).

Stake
6.10%
Shares
11,842,434
Intent
Active
What changed
Stake changed
Filed together
7 holders

The filing in full

HolderStakeShares
VIKING GLOBAL INVESTORS LP6.10%11,842,434
Viking Global Opportunities Parent GP LLC6.10%11,842,434
Viking Global Opportunities GP LLC6.10%11,842,434
Viking Global Opportunities Portfolio GP LLC6.10%11,842,434
Viking Global Opportunities Illiquid Investments Sub-Master LP6.10%11,842,434
HALVORSEN OLE ANDREAS6.10%11,842,434
Shabet Rose Sharon6.10%11,842,434

Source

View original at SEC

Related